000739.SZ · 普洛药业
China A-shares · RS rating 98 · As of 2026-10-14
| Price | 24.59 CNY |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 94 / 96 / 92 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 51 / 43 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -2.9% |
| Distance from 52-week high | +11.4% |
| Market cap (USD) | $4.4B |